Provided by Tiger Trade Technology Pte. Ltd.

Insulet

148.66
+3.532.43%
Volume:480.10K
Turnover:70.67M
Market Cap:10.30B
PE:28.07
High:149.68
Open:142.93
Low:142.01
Close:145.13
52wk High:354.88
52wk Low:126.40
Shares:69.26M
Float Shares:69.07M
Volume Ratio:0.62
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.30
EPS(LYR):3.48
ROE:26.02%
ROA:9.71%
PB:7.24
PE(LYR):42.73

Loading ...

Dexcom Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 25

Insulet initiated with a Buy at Deutsche Bank

TIPRANKS
·
Jun 24

Can Insulet’s (PODD) Closed-Loop Type 2 Data Reframe Its Long-Term Diabetes Tech Narrative?

Simply Wall St.
·
Jun 23

Deutsche Bank Initiates Coverage on Insulet With Buy Rating, $190 Price Target

MT Newswires Live
·
Jun 23

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Pfizer (PFE) and Insulet (PODD)

TIPRANKS
·
Jun 23

Insulet Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 23

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 19

Insulet Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Jun 18

Insulet Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 16

Piper Sandler Keeps Their Buy Rating on Insulet (PODD)

TIPRANKS
·
Jun 15

Insulet Is Maintained at Buy by Truist Securities

Dow Jones
·
Jun 12

Insulet Corp : Truist Securities Cuts Target Price to $219 From $250

THOMSON REUTERS
·
Jun 12

Insulet Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 12

Analysts Have Conflicting Sentiments on These Healthcare Companies: Eli Lilly & Co (LLY), Insulet (PODD) and Novartis (NVS)

TIPRANKS
·
Jun 12

Insulet price target lowered to $219 from $250 at Truist

TIPRANKS
·
Jun 12

Truist Securities Cuts Insulet Price Target to $219 From $250, Keeps Buy Rating

MT Newswires Live
·
Jun 12

Insulet Corp. Stock Slides 5.6%, Underperforms Peers

Dow Jones
·
Jun 11

Movement Alert|Insulet Falls 5.12% in Regular Trading, Trading at $151.195

Market Focus
·
Jun 11

Raymond James Adjusts Price Target on Insulet to $216 From $263, Maintains Outperform Rating

MT Newswires Live
·
Jun 09

Wells Fargo Reaffirms Their Buy Rating on Insulet (PODD)

TIPRANKS
·
Jun 09